» Articles » PMID: 36499544

The Role of Epigenetics in Neuroinflammatory-Driven Diseases

Abstract

Neurodegenerative disorders are characterized by the progressive loss of central and/or peripheral nervous system neurons. Within this context, neuroinflammation comes up as one of the main factors linked to neurodegeneration progression. In fact, neuroinflammation has been recognized as an outstanding factor for Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and multiple sclerosis (MS). Interestingly, neuroinflammatory diseases are characterized by dramatic changes in the epigenetic profile, which might provide novel prognostic and therapeutic factors towards neuroinflammatory treatment. Deep changes in DNA and histone methylation, along with histone acetylation and altered non-coding RNA expression, have been reported at the onset of inflammatory diseases. The aim of this work is to review the current knowledge on this field.

Citing Articles

Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases.

Denaro S, DAprile S, Vicario N, Parenti R Front Cell Neurosci. 2025; 19:1532960.

PMID: 40007760 PMC: 11850338. DOI: 10.3389/fncel.2025.1532960.


The Role of Epigenetic Mechanisms in the Development of PM-Induced Cognitive Impairment.

Jiang L, Shao M, Song C, Zhou L, Nie W, Yu H Toxics. 2025; 13(2).

PMID: 39997934 PMC: 11861554. DOI: 10.3390/toxics13020119.


Bee Pollen Phytochemicals and Nutrients as Unequaled Pool of Epigenetic Regulators: Implications for Age-Related Diseases.

Kacemi R, Campos M Foods. 2025; 14(3).

PMID: 39941940 PMC: 11816923. DOI: 10.3390/foods14030347.


Assessment of relationships between epigenetic age acceleration and multiple sclerosis: a bidirectional mendelian randomization study.

Liu H, Zhang H, Yin Z, Hou M Epigenetics Chromatin. 2025; 18(1):7.

PMID: 39885544 PMC: 11780769. DOI: 10.1186/s13072-025-00567-9.


The Intersection of Epigenetics and Senolytics in Mechanisms of Aging and Therapeutic Approaches.

Burdusel D, Doeppner T, Surugiu R, Hermann D, Olaru D, Popa-Wagner A Biomolecules. 2025; 15(1).

PMID: 39858413 PMC: 11762397. DOI: 10.3390/biom15010018.


References
1.
Ma Q, Oksenberg J, Didonna A . Epigenetic control of ataxin-1 in multiple sclerosis. Ann Clin Transl Neurol. 2022; 9(8):1186-1194. PMC: 9380165. DOI: 10.1002/acn3.51618. View

2.
Kaas G, Zhong C, Eason D, Ross D, Vachhani R, Ming G . TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron. 2013; 79(6):1086-93. PMC: 3816951. DOI: 10.1016/j.neuron.2013.08.032. View

3.
Wang L, Chen K, Wan X, Wang F, Guo Z, Mo Z . NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation. Biochem Biophys Res Commun. 2017; 484(4):871-877. DOI: 10.1016/j.bbrc.2017.02.007. View

4.
Bartlett R, Sluyter V, Watson D, Sluyter R, Yerbury J . P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1 amyotrophic lateral sclerosis mice. PeerJ. 2017; 5:e3064. PMC: 5335685. DOI: 10.7717/peerj.3064. View

5.
Panto M, Cicirata F, ANGAUT P, Parenti R, Serapide F . The projection from the primary motor and somatic sensory cortex to the basilar pontine nuclei. A detailed electrophysiological and anatomical study in the rat. J Hirnforsch. 1995; 36(1):7-19. View